ALGS announces fan-driven events and creator showdown for split 2 playoffs
60% off Profit Pro - Limited Time Offer!
141.15MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US01626L1052
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
15.07
Dividend Share
-
Dividend Yield
-
Earnings Share
-7.25
Wall Street Target Price
103.3333
EPS Estimate Current Year
-10.36
EPS Estimate Next Year
-13.005
EPS Estimate Current Quarter
-2.16
EPS Estimate Next Quarter
-1.49
Most Recent Quarter
-
Revenue TTM
5,997,000
Gross Profit TTM
-71,170,000
EBITDA
-92,684,000
Profit Margin
0.00%
Return On Assets TTM
-67.32%
Return On Equity TTM
-146.69%
Revenue Per Share TTM
1.005
Qtly Revenue Growth YOY
-60.80%
Diluted Eps TTM
-7.25
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
23.5364
Price Book MRQ
2.8175
Enterprise Value Revenue
12
Enterprise Value EBITDA
0
115.38
1.29%88.70
1.04%409.38
0.36%715.42
0.13%243.68
0.09%630.10
0.02%630.00
0.00%173.50
0.00%198.28
0.00%99.02
-0.96%See which Billionaires own this investment
ALGS announces fan-driven events and creator showdown for split 2 playoffs